Hepatocyte proliferation was analyzed in vivo during the time course of continuous administration to rats of the liver tumor promoter ethinyl estradiol (EE) at 10 p.p.m. in the diet. EE-induced acute liver hyperplasia was detected in male and female Sprague-Dawley rats as an increased mitotic index of hepatocytes after 2 days of treatment. 5'-Bromodeoxyuridine (BrdU) labeling showed that proliferating hepatocytes were randomly distributed throughout the hepatic lobule. Subsequently, and still during the first few days of continuous EE treatment, hepatocyte proliferation decreased to control levels, and a transient increase in the incidence of apoptosis in the liver was detected. Although consistent with the concept of liver growth regression after mftogen-induced hyperplasia, these results differ from others reported to date in that, in our experiments, the cessation of cell proliferation and the subsequent growth regression occurred without withdrawal of EE in our experiments. After returning to control levels, hepatocellular proliferation again increased between 3 and 6 months of chronic treatment and remained activated during the following months of continuous treatment, as seen by accumulative BrdU labeling. Proliferating hepatocytes were predominantly located in zone 2 of the hepatic lobule at this time, surrounding a periportal zone of vacuolated hepatocytes, which were also induced by the treatment. Moreover, hyperplasia of basophilic hepatocytes was also seen around some portal spaces. In another set of experiments, chronic EE-induced activation was characterized by flow cytometry on hepatocytes isolated from male Fischer rats. Ploidy analysis of hepatocyte cell suspensions showed that the normal polyploid pattern of hepatocytes was altered by EE, the proportion of diploid hepatocytes rising considerably. The results also showed that these diploid cells were the most susceptible hepatocyte population to EE-induced proliferation, as shown by a combination of BrdU labeling and cell sorting methods. In contrast to Sprague-Dawley rats, no vacuolated cells were found histologically in the livers of these animals and the proliferating hepatocytes were located adjacent to the portal areas. These results taken together support the existence of cell target populations in the liver responding to the effects of tumor promoters. The finding that a subpopulation of diploid hepatoyctes was the liver cell class most susceptible to proliferation during chronic EE
Introduction
The term non-genotoxic hepatocarcinogens comprises a number of agents which enhance liver tumor development when administered to experimental animals without evidence of genetic damage to hepatocytes. Some of these agents can induce liver tumors by themselves over long periods of exposure, behaving as 'complete' carcinogens, such as some peroxisomal proliferators (1) or a choline-deficient diet (2) . Others only induce a very low incidence of tumor formation when administered alone, and often exert their main carcinogenic action on hepatocytes initiated by a genotoxic carcinogen. These so-called tumor promoters expand die population of initiated hepatocytes in the form of preneoplastic foci and enhance their progression to hepatocellular carcinoma (3) . The distinction between the two kinds of agent, non-genotoxic 'complete' carcinogens and tumor promoters, is unclear since the former can often behave as promoters. The mechanisms by which non-genotoxic carcinogens and/or tumor promoters enhance hepatocarcinogenesis are not fully understood, almough extensively studied. It is conceivable that the creation of a promotable cell involves a modification of die response to extracellular or intracellular signals, by which a promoting treatment induces the selection and the clonal expansion of the initiated cells (4) .
A ubiquitous aspect of hepatocarcinogenesis is die enhancement of the growui of preneoplastic hepatocytes during me promoting treatments. In the hepatocyte resistant model (5), carcinogen-initiated hepatocytes can be induced to selective growth by a regenerative stimulus during treatment by 2-acetylaminofluorene, owing to the resistance of initiated hepatocytes to the cytostatic agent. Further, preneoplastic foci have been shown to be more susceptible than the surrounding normal liver to cell proliferation induced by some tumor promoters (6) . On the other hand, the impairment of preneoplastic focus regression can also play an important role in preneoplastic growth, as has been shown during promotion by phenobarbital (7) . In die normal liver, most of non-genotoxic carcinogens activate hepatocellular proliferation, many of them acting as direct liver mitogens inducing acute liver hyperplasia (8) . Others induce liver cell death and provoke a regenerative response of die liver to compensate for the cell loss (9, 10) , as partial hepatectomy does. In this respect, hepatic cell injury and regeneration repeated chronically has been closely associated with the induction of hepatic neoplasias in the absence of other carcinogenic stimuli (9) . A recent study by Cunningham etal (11) illustrates die importance of cell proliferation in the carcinogenic process. These authors show that whereas the genotoxic aromatic amine isomers 2,4-and 2,6-diaminotoluene are equally mutagenic and metabolized by die liver, only the latter has carcinogenic effects in rodent liver, which is correlated with its unique capacity of increasing hepatocyte proliferation.
Ethinyl estradiol (EE*) is a synthetic steroid that has been associated with the increased incidence of hepatic neoplasias in women taking oral contraceptives (12) . Experimental studies in animals have shown that EE is a liver tumor promoter, having no detectable mutagenic or initiating activity (13) . A weak ability of EE to induce hepatocellular adenomas or carcinomas in the absence of an exogenous initiating stimulus has been reported (14) , which may be attributable to a low level of spontaneously initiated cells in the normal liver (15) . EE induces acute liver hyperplasia in the normal liver (16) and when administered chronically, increased levels of hepatocellular proliferation can also be detected (17, 18) . In ovariectomized female rats, it has been shown that treatment with EE induces an increase in the diploid population of hepatocytes (19) and the involvement of specific populations of hepatocytes in the induced growth effects has been suggested (18) . Several mechanisms are believed to be involved in hepatic growth activation by EE, such as the mediation of the liver estrogen receptor (19) or the induction of a serum factor which stimulates hepatocyte growth (20) . However, it is still uncertain how proliferative activation and tumor promotion by EE in the liver are related.
In the present paper, we analyzed the characteristics of hepatocyte proliferation during the time course of EE administration to normal rats. The purpose of the study was to delimit and characterize the periods of liver growth resulting from continuous treatment with EE and to ascertain whether specific populations of hepatocytes were involved in the growth response to the treatment. From the results of this study, we conclude that chronic effects of EE treatment on hepatocellular proliferation may be involved in the ability of the steroid to promote hepatocarcinogenesis. Furthermore, the proliferative activation of a specific subpopulation of diploid hepatocytes may be a mechanism of tumor promotion by this compound.
Materials and methods

Treatment of the animals
Twelve week old male and female Sprague -Dawley rats were continuously fed a UAR (Usine d'Alimentation Rationelle) defined diet (Panlab, Barcelona) containing 10 p.p.m. of EE (Sigma, St Louis, MO), and control animals were fed the same diet without the steroid. The estimated daily dose of EE was 0.5 mg/kg body weight. After 2 days of EE treatment, four rats were injected with 5'-bromodeoxyuridine (BrdU) (50 mg/kg body weight) and killed by decapitation 1 h later. Other animals were killed after 3 and 7 days of treatment. Another group of animals was treated for 3, 6 and 9 months with the EE-containing diet and were given BrdU in their drinking water (0.8 mg/ml) for 3 days before being killed. These experiments were performed in Barcelona.
Male Fischer 344 rats aged 12 weeks from another laboratory (Carshalton) were fed a diet containing 10 p.p.m. of EE dissolved in arachis oil, for 6 and 12 months, after which they were killed. Control animals were fed a normal diet containing the vehicle alone. Three days before killing, all the animals were given BrdU in the drinking water as described above.
All the animals were maintained under standard conditions according to the European community guidelines (86/609/EC), and food and water were given ad libitum.
Tissue collection and hhtologicaJ methods
Sprague-Dawley animals were killed by decapitation under ether anesthesia and the livers were removed for histological sampling. Some liver samples were frozen in isopentane-liquid nitrogen and stored at -80°C for 7-glutamyhranspeptidase (GGT) histochernistry (21) and periodic acid Schiff (PAS) staining (22) . Other liver samples were fixed in buffered 2% paraformaldehyde at 4°C or in Camoy's fixative overnight and embedded in paraffin. Sections from formaldehyde-fixed tissue were stained with hematoxylin-eosin and mitotic and apoptotic counts were performed on them. Immunohistochemistry for the detection of cytokeratin 19 (CK19) and a-fetoprotein (aFP) was performed on sections from formaldehydefixed tissue using a mouse monoclonal antibody to CK19, clone RK7 (23), Irindly donated by A.Quaroni (Cornell University, Ithaca, NY), and a sheep poryclonal aniserum to aFP (Cuhek, Barcelona). These two antibodies were checked to ensure the retention of antigen reactivity on our formaldehyde-fixed and paraffin-embedded material, using the appropriate positive controls. A rabbit polyclonal antiserum raised against the Yp subunit of rat glutathione S-transferase (GST; Bioprep Ltd, Dublin, Ireland) was used on sections of both formaldehyde-and Camoy's-fixed tissue. BrdU immunohistochemistry was performed on sections of Camoy's fixed tissue using a mouse monoclonal antibody, clone BU-1 (Amersham, Buckinghamshire, UK). Suitable peroxidase-conjugated antisera (Dakopatts, Denmark) were used for each primary antibody and developed with diaminobenzidine, following conventional immunohistochemica] methods.
For electron microscopy studies, livers were fixed in 2% paraformaldehyde + 1.5% glutaraldehyde dissolved in 0.01 M phosphate buffer adjusted to 500 mosm by sucrose. Postfixation was performed with 1 % osmium tetroxide, and after dehydration, the samples were embedded in Araldite resin (Fluka, Buchs, Switzerland). Ultrathin sections were counterstained with lead citrate and uranyl acetate.
Before collagenase perfusion of the livers from Fischer rats, one of the caudate lobes was ligated and removed from each liver. It was divided in two parts which were fixed in Camoy's fixative or in cold acetone overnight for BrdU immunohistochemistry and GGT histochernistry respectively, and embedded in paraffin.
Hepatocyte isolation
Isolated hepatocytes were obtained from male Fischer rats by means of liver collagenase perfusion. After anesthetizing the animals with Sagatat® (0.7 ml/200 g body weight), the livers were perfused via the portal vein using 400 ml of Hank's balanced salt solution without Ca 2+ or Mg 2 " 1 ", but containing 0.13% sodium bicarbonate, at a flow rate of 50 ml/min and oxygenated with 95% O^ + 5% CO2. A recirculating perfusion was then performed adding 0.08% collagenase H (Boehringer Mannheim, Germany) to the perfusing medium for 20-30 min at 37°C. When perfusion was finished, livers were broken up by cutting Glisson's capsule and gentle shaking in William's E culture medium containing 0.0022% sodium bicarbonate, 5% fetal calf serum and 0.025% gentamycin (Gibco, Life Technologies Ltd, Middlesex, UK). The cell suspensions were filtered through a 50 /un mesh gauze and hepatocytes were separated from non-parenchymal cells by centrifugation at 50 g repeated three times. Microscopic analysis of isolated hepatocytes showed that contamination by non-parenchymal cells was negligible.
From the freshly isolated hepatocytes, some samples were cytospun onto slides to calculate, under the microscope, total percentages of binucleated hepatocytes and histochemically detected GGT-expressing hepatocytes.
Flow cytometry studies
Flow cytometry studies were carried out using an Ortho cytofluorograf system 50-H model 2150, equipped with an argon laser emitting at 488 nm. Samples from freshly isolated hepatocytes were stained in a 0.005% aqueous ethidium bromide solution containing 0.1 % sodium citrate, 0.1 % Triton X-100 and 5% ribonuclease A. After controlled sonication to remove cytoplasms and release nuclei, the ploidy distributions of hepatocyte nuclei were calculated by flow cytometry, measuring the red fluorescence emitted by ethidium bromide. Other samples of intact hepatocytes were fixed in 70% ethanol and kept at -40°C. BrdU immunofiuorescence was performed on these fixed cells after DNA denaturation with 0.1 N HCI using a rat monoclonal antibody to BrdU (kind gift from Dr Chris Dean, Institute of Cancer Research, Sutton, UK) and a fluoresceinconjugated second antibody to rat IgG from goat (Sigma). Cells were finally stained using a 5% propidium iodide solution in PBS for ploidy measurement. Thus, the total percentage of BrdU-incorporating hepatocytes and bivariate distributions green (BrdU) versus red (propidium iodide) fluorescences were obtained by flow cytometry.
The bivariate distributions of BrdU versus propidium iodide showed that, after the 3 days of continuous administration with BrdU, most of the labeled hepatocytes were concentrated above each of the three cell ploidy peaks: 2N, 4N and 8N. Thus, after calculating the percentages of BrdU-labeled hepatocytes in each of these three peaks, cell sorting was performed on slides by flow cytometry of BrdUpositive and -negative 2N, 4N and 8N cells. Further counting under the microscope of the proportion of binucleated cells in each sorted cell fraction gave the relative percentage of BrdU positive cells in each ploidy pouplation of hepatocytes: mononucleated and binucleated 2N and 4N cells, and mononucleated 8N cells. A similar protocol of cell sorting was also performed on ethanol-fixed cells only stained with propidium iodide. After sorting total 2N, 4N and 8N cells on slides, GGT histochemical staining was performed and proportions of binucleated cells and GGT-positive cells were calculated under the microscope in each sorted cell fraction. Thus, the percentage of GGT-positive cells in each ploidy population of hepatocytes was obtained.
Statistics
Data management and statistical analysis were performed using the software package SPSS/PC+™ V4.0. After checking the normal distribution of the variables by means of the Kolmogorov-Smimov test, significant differences were evaluated using the multi-analysis of variance (MANOVA) with respect to control values, time of treatment and sex. The level of significance taken was P = 0.05.
Results
Acute hepatic hyperplasia
The ability of EE to induce liver hyperplasia was detected as an increase in the mitotic index of hepatocytes from male and female Sprague-Dawley rats continuously fed the EE-containing diet ( Figure 1 ). The increased mitotic index reached a peak after 2 days of treatment, at the same extent in both sexes, and declined to control levels after 3 days of treatment. BrdU administration at this time, and further immunohistochemical detection showed that the labeled hepatocytes were randomly distributed throughout the hepatic parenchyma (Figure 2) .
To ascertain whether apoptosis occurs after acute liver hyperplasia during continuous treatment by EE, the incidence of apoptotic bodies was calculated in the livers of these animals. They were recognized as round eosinophilic cytoplasm containing one or more fragments of condensed chromatin, as described (24) . The results showed that the apoptotic index increased in males in as soon as 3 days after treatment, having returned to control levels after 1 week of treatment (Figure 1 ). In females, although the increase at 3 days was at the limits of significance (P = 0.057), the same tendency was shown ( Figure 1 ).
Chronic hepatic activation in male and female Sprague-Dawley rats
Chronic treatment of these Sprague-Dawley rats with EEcontaining diet resulted in a second increase in the levels of hepatocyte proliferation, as detected by an accumulative BrdU labeling index. After 3 days of continuous BrdU administration, the percentages of BrdU-labeled nuclei of hepatocytes on the sections were increased in the EE-treated animals with respect to the controls at 6 and 9 months of treatment, but not at 3 months (Figure 3 ). In males, the increase in hepatocyte proliferation tended to be proportional to the exposure to EE, whereas in females the levels reached at 6 months were maintained at 9 months. The mean values of the mitotic indexes at 6 months of treatment, 0.061 in males and 0.056 in females, showed that this chronic activation was -3-to 4-fold lower when compared to the levels reached during acute hyperplasia. However, whereas acute hyperplasia was completed in a few days, the chronic activation spanned several months. The total growth effects induced were thus much higher during the chronic activation.
In contrast to acute hyperplasia, no increased levels of apoptosis could be detected in these chronically treated animals, nor any other sign of tissue necrosis. However, toxic effects on the liver were found. Cytoplasmic vacuolization was detected histologically in periportal hepatocytes ( Figure 4A ). These cytoplasmic vacuoles did not contain glycogen since they were PAS-negative ( Figure 4B ) and glycogen was never found inside them when observed under the electron microscope ( Figure 4C ). Ultrastructurally, these vacuoles were coated by membrane and were associated with a dilated and vesicularizing endoplasmic reticulum ( Figure 4C and D) . Some mitochondria also appeared swollen. Livers from control animals or pericentral-vein regions from livers of the same treated animal did not show these alterations, ruling out the possibility of an artifactual origin. Vacuolated cells also displayed staining for GGT at the canalicular membrane ( Figure 4E ). In contrast to acute hyperplasia, BrdU-labeled hepatocytes were mainly concentrated in zone 2 of the hepatic lobule surrounding the area of vacuolated hepatocytes (Figure 2) .
In both control and treated animals, a very low number of small foci and single hepatocytes positive for the preneoplastic marker GST were scattered in the liver sections. Their number or size was not affected by EE treatment (data not shown). However, E6m C9m E9m Fig. 3 . Percentages of BrdU-labeled nuclei of hepatocytes (DO. of labeled nuclei/100 nuclei), measured on immunohistochemically-stained liver sections, from male (white bars) and female (shaded bars) Sprague -Dawley rats continuously fed EE-containing diet for 3, 6 and 9 months, and controls. The animals were given BrdU dissolved in the drinking water (0.8 mg/ml) for 3 days before killing. Only one out of five males treated for 3 months showed an increased value, but the resulting mean was not significantly increased. The values shown are the mean =fc SD from four to six animals. "Increased with respect to the corresponding control, P < 0.05. 'increased with respect to 9 month-treated females, P < 0.05.
a distinct class of larger hyperplastic foci was occasionally detected in the liver sections of animals treated for 6 and 9 months with EE, but never in those treated for 3 months or less. These foci did not show any detectable expression of the preneoplastic markers GGT and GST. They were also characterized by the presence of a high number of BrdU-positive hepatocytes and histologically they were mainly formed by mixed eosinophilic/ clear cells. A small number of basophilic and clear cell foci was also apparent. Furthermore, basophilic hepatocytes were also found periportally in a region between the portal triads and the periportal vacuolated areas in most of the animals treated with EE for 6 and 9 months. Like the vacuolated hepatocytes, they also showed histochemical staining for GGT. In some instances, these hepatocytes formed diffuse hyperplastic areas with many of the cells positive for BrdU ( Figure 4F and G). Immunohistochemical detection of the GST, CK19 and AFP proteins, which are histochemical markers associated with bile duct/oval cells, did not show any staining in these hyperplastic areas. Neither such hyperplastic areas nor GGT,GST-negative foci were observed in the control animals. Thus, apart from the proliferating hepatocytes of zone 2, two other cell populations in the livers of chronically treated Sprague-Dawley rats responded to EE in the form of hyperplastic foci and basophilic hyperplastic periportal areas.
Chronic activation on hepatocyte ploidy populations in male Fischer rats
To determine the involvement of the different hepatocyte ploidy populations in the proliferative effects during chronic treatment with EE, flow cytometry studies were performed on male Fischer rats fed the control and the EE-containing diets for 6 and 12 months. BrdU was given to the animals for 3 days before killing and its incorporation into hepatocytes was measured by immunofluorescence and flow cytometry. The BrdU index of hepatocytes was significantly higher in EE-treated animals than in controls, for both lengths of treatment, and at similar levels to those found with Sprague-Dawley rats (Table I) . Two animals which were treated for 3 months did not show increased levels of hepatocyte proliferation with respect to controls (data not shown). However, in contrast to the Sprague-Dawley rats, BrdU-labeled hepatocytes were localized in the more proximal region of the hepatic lobule, surrounding the portal triads (Figure 2) , and no signs of cell vacuolization or periportal basophilia were found. Occasionally, some GGT.GST-negative hyperplastic foci also appeared in the treated animals. Ploidy distributions measured by flow cytometry from nuclei of isolated hepatocytes showed that the percentage of 2N nuclei increased and that of 4N and 8N nuclei decreased in the EEtreated animals with respect to controls ( Table I ). The differences were much more striking at 6 months of treatment, and the ploidy distributions at 12 months tended to return to the control proportions. There were no significant differences in the percentages of total mononucleated and binucleated hepatocytes between EE-treated and control animals ( Table I) .
To determine whether any ploidy population of hepatocytes was more susceptible to the growth effects of EE, the percentage of BrdU-labeled hepatocytes with respect to each population was calculated from the EE-treated animals. Two cell populations showed higher levels than the average: mononucleated diploids (MD) and mononucleated octaploids (MO) ( Figure 5 ). The fact that many mitotic cells were found in the MO cell sorted fraction and the fact that BrdU was still being administered to the animals at the time of killing, suggest that a number of BrdU-labeled mononucleated tetraploids (MT) in the G 2 /M phase of the cell cycle contaminated the MO cell sorted fraction. Because of the low number of cells in the MO population when compared to the others (Table I) , a percentage of BrdU-labeled MO cells similar to the average was probably artificially increased by the presence of a minority of the BrdU-labeled MT cells, those in G2/M. According to this, MD cells would be the proliferating population more responsive to EE.
GGT was histochemically detected in periportal areas of the hepatic lobule in all the EE-treated animals, where BrdU-positive hepatocytes were also found. The percentages of GGT-expressing hepatocytes from cell suspensions increased significantly from 42% at 6 months to 52% at 12 months ( Figure 6 ). Control animals did not show GGT staining in hepatocytes either on the sections or in the cell suspensions. To ascertain whether any ploidy population of hepatocytes was predominantly located in the periportal areas, the percentage of GGT-expressing hepatocytes was calculated for each population, considering GGT expression as a marker of cell location in the hepatic lobule. The results showed that the percentages of GGT-expressing cells were represented by similar or slightly lower values than those found for total isolated hepatocytes in all cases except the binucleated diploid (BD) population, which displayed an increased value ( Figure 6 ). This means that in the EE-treated animals all the ploidy populations were more or less randomly distributed between periportal and pericentral-vein regions, except for the BD cells, which tended to concentrate in periportal areas. It is thus apparent that it was not the entire MD population but only the fraction found in the periportal region that was the most susceptible to proliferative activation by chronic EE treatment.
Discussion
Many non-genotoxic hepatocarcinogens induce liver enlargement by cellular hypertrophy and by proliferation of hepatocytes and other hepatic cells during the first few days of treatment (8) . This hyperplastic effect contributes to an increase in liver mass which subsequently decreases to the original size by reduction in cellular volume and through the mechanism of controlled cell death The number of labeled hepatocytes/100 hepatocytes (% BrdU + ) and the percentages of 2N, 4N and 8N nuclei (% nuclear ploidy) were calculated by flow cytometry, and the percentages of binucleated cells (% Bin) were calculated by direct counting under the microscope. The animals were given BrdU dissolved in drinking water (0.8 mg/ml) for 3 days before killing. The values shown are the mean ± SD from four animals. "Increased with respect to the corresponding control, P < 0.05. Decreased with respect to the corresponding control, P < 0.05. Tendency to decrease with respect to the control, P < 0.056. d Decreased with respect to the 6-month treated animals, P < 0.05. 'Increased with respect to the 6-month treated animals, P < 0.05. Relative percentages of BrdU-labeled hepatocytes in each ploidy population of hepatocytes MD, mononucleated diploids; BD, binucleated diploids; MT, mononucleated tetraploids; BT, binucleated tetraploids; MO, mononucleated octoploids) calculated by flow cytometiy (as described in Materials and methods), from male Fischer rats continuously fed the diet containing EE for 6 (white bars) and 12 (shaded bars) months. BrdU was given in the drinking water (0.8 mg/ml) for 3 days before killing. In each animal, the relative percentage of BrdU for each ploidy class was calculated with respect to the total percentage of BrdU of this animal. The values shown are the mean ± SD from four animals. "Increased whh respect to the total population, P < 0.05. 'Decreased with respect to the total population, P < 0.05. . Percentages of GGT-expressing hepatocytes in the total population and in each ploidy population of hepatocytes (MD, mononucleated diploids; BD, binucleated diploids; MT, mononucleated tetraploids; BT, binucleated tetraploids; MO, mononucleated octaploids) calculated by flow cytometry and GGT histochemistry of cell sorted fractions (as described in Materials and methods), from male Fischer rats continuously fed the diet containing EE. The values shown are the mean ± SD from four animals. "Increased with respect to 6-month treated animals, P < 0.05. '"Increased with respect to the value of the total population, P < 0.05. Ttecreased with respect to the value of the total population, P < 0.05.
termed apoptosis (8, 24) . Acute liver hyperplasia induced by EE has already been described (16), and we detected it as a transient increase in the mitotic activity of hepatocytes. Our results also showed that this activation was immediately followed by an increased incidence of apoptosis in the liver, thus confirming for EE the sequence of events characteristic of mitogen-induced acute hyperplasia in the liver. However, with all the other mitogens reported elsewhere, the regression of liver growth occurs upon cessation of mitogen administration, but in our experiments withdrawal of EE was not a requirement for this effect. This suggests a substantial difference in the hyperplastic mechanisms between EE and other liver mitogens. Despite this difference, acute hyperplasia induced by EE or other compounds does not seem to have enhancing effects on hepatocarcinogenesis. Our previous studies on the promoting ability of EE showed that only a long exposure (8 months) to this compound was effective in promoting the growth of preneoplastic foci induced by diethylnitrosamine (DEN), a short exposure being ineffective (3 or 4 months) (17) . Moreover, in contrast to agents that cause compensatory liver growth in response to hepatic cell loss, such as partial hepatectomy or carbon tetrachloride, other liver mitogens that direcdy induce acute hyperplasia have been shown to be unable of supporting the growth of carcinogen-induced initiated hepatocytes administered either as cocarcinogens or promoters (25, 26) . Although the cause of this behavior is not known, apoptosis after acute liver hyperplasia may counteract the mitogenic effects of these compounds on the growth of the carcinogen-induced preneoplastic hepatocytes. Therefore, these results suggest that the acute hyperplastic effects of EE on the liver are not involved in the promoting ability of the steroid.
Our results also showed that after acute hyperplasia and some time at the basal levels of liver cell proliferation, continuous treatment with EE resulted in chronic activation of hepatocyte proliferation. In a previous paper (17), we already mentioned this effect and pointed out as a preliminary result that an increased level of cell death in the livers of chronically treated animals might be responsible for a chronic compensatory activation of hepatocyte proliferation. The analysis made in the present work revealed that the incidence of apoptosis in control and EE-treated Sprague-Dawley animals was not different at this stage of the treatment, and no evidence of any other kind of tissue necrosis was found. However, chronic EE treatment provoked cell damage in the liver, as shown by the cytoplasmic vacuolization induced in the periportal hepatocytes of these animals. Such a toxic effect may be related to changes induced in the lipid composition of hepatocyte membranes by treatment with synthetic steroids, which leads to increased membrane rigidity and affects the activity of certain membrane-bound enzymes, such as Na + ,K + -ATPase (27) . A disfunction in the osmotic balance of the endoplasmic reticulum caused by alterations in membrane permeability may have provoked a swelling of the organelle and the formation of the cytoplasmic vacuoles observed in our experiments. Further, overexpression of the enzyme GGT in these hepatocytes has been associated with intrahepatic cholestasis induced by treatment with synthetic steroids (28) . It is thus suggested that periportal hepatocytes in Sprague-Dawley rats display the toxic effects of EE treatment, and this toxicity might account for an impairment in the cell liver function which could trigger hepatocyte proliferation, tending to restore the full function of the organ. With regard to the Fischer rats, the periportal vacuolization was not detected at any stage of the treatment. This fact, although not ruling out hepatotoxicity in these animals, may reflect strain differences in the response of the liver to the treatment. The extent of the proliferative response was, however, found to be similar in both strains. In any case, the ability of EE to promote the growth of preneoplastic foci induced by DEN was only seen after a long exposure time to the compound (17), a similar requirement to that for the shift of the chronic proliferative activation described in the present study. This therefore suggests that the chronic effects of EE on hepatocyte proliferation detected in non-initiated liver, or parallel effects on the cell physiology or metabolism, have a role in the ability of EE to enhance preneoplastic growth.
In this study we also report that the activation of hepatocellular proliferation by chronic treatment with EE seemed to involve specific populations of hepatocytes. Whereas in the acute hyperplastic activation BrdU-labeled hepatocytes were randomly distributed in the hepatic lobule (Figure 2A) , labeled hepatocytes during chronic activation were located in zone 2 of the lobule, surrounding the periportal areas of vacuolated hepatocytes ( Figure  2B ). This occurred in Sprague-Dawley rats, but in Fischer rats, which did not show such periportal vacuolization, the labeled hepatocytes appeared to be concentrated in the nearest parenchyma to the portal triads ( Figure 2C ). The adult liver is formed by a slow-renewing population of hepatocytes, and it has been described that young cells in the periportal region progress to the pericentral-vein region as functional specialization or differentiation takes place (29) . So, it may be suggested that a population of young, less differentiated periportal hepatocytes respond to the mitogenic stimulus provoked by chronic EE treatment. The same may occur during the proliferative activation by other stimuli like partial hepatectomy (30) or lead nitrate (26) , which also induce proliferation of periportal hepatocytes in adult livers. In agreement with this, it has recently been reported that the stimulation of DNA synthesis by epidermal growth factor (EGF) in cultured periportal hepatocytes was higher than in pericentral-vein hepatocytes (31) . However, this does not rule out the possibility that other compounds, such as phenobarbital, may induce proliferation of centrilobular hepatocytes, by a mechanism possibly related to the activation of specific metabolic gene programs in more differentiated hepatocytes (8) . The fact that in Sprague-Dawley rats proliferation took place in zone 2 of the hepatic lobule may be explained if periportal vacuolated hepatocytes represent a target population for the cytotoxic effects of EE. Then, the response to the mitogenic stimulus would be carried out by the next youngest population that follows in the hepatic lobule, namely, that in zone 2.
We also identified that a number of the BrdU-labeled hepatocytes, basophilic and not vacuolated, were concentrated in hyperplastic diffuse areas adjacent to some portal triads in Sprague-Dawley rats. This suggests that there was a periportal hepatocyte population with a high susceptibility to proliferation by chronic EE treatment, which led to the formation of such hyperplastic areas. Morphological appearance and lack of expression of some oval cell markers (GST, CK19 and AFP) suggested that these basophilic cells were hepatocytes and had no apparent relationship to the oval cells that emerge in response to certain carcinogenic treatments (32) .
In addition to these hyperplastic areas, chronic EE treatment induced the appearance of hyperplastic foci with a high degree of BrdU-labeled cells. They may have arisen from spontaneously initiated hepatocytes, a mechanism pointed out previously (15) . The fact that they were negative for the common preneoplastic markers GST and GGT contrasts with the fact that most of the DEN-induced preneoplastic foci showed detectable expression of GST in the two-stage model of carcinogenesis using DEN and EE (17) . The number and size of the few, small GST-positive foci present in the control livers was not affected by the EE treatment.
The hepatocyte population of an adult liver is composed of different ploidy classes of hepatocytes: diploid, tetraploid and octoploid cells, and also binucleated cells. From the birth of the animal, when all the hepatocytes are diploid, there is a phenomenon of polyploidization, i.e. the appearance of higher cell classes of ploidy, which increase in proportion with the age of the animal (33) . It was part of our purpose to establish which ploidy classes were more responsive to the growth effects induced by chronic EE treatment, and how that affected the ploidy of hepatocytes. The results of BrdU labeling experiments suggest that MD cells were the most responsive hepatocyte population to the growth effects of EE, although proliferation was also activated to a lesser extent in the rest of the populations. In addition, this increased susceptibility was found only in a subpopulation of these cells, namely, those located periportally, since it was shown that all the cell ploidy classes were randomly distributed throughout the hepatic lobule, except for the BD cells. Our results also showed that the diploid population increased in proportion, and the higher ploidies decreased, as a result of chronic EE treatment. These changes tended to give way to normal distributions at 12 months of treatment. One interpretation is that the expansion of diploid cells in number by responding to chronic EE treatment caused a reduction of all the other ploidies as a proportion. The eventual return to a near normal pattern might indicate that the proliferating diploid cells also underwent polyploidization. It is well known that diploidization is a general phenomenon observed in preneoplastic lesions induced by many hepatocarcinogens, including DEN (34) . Moreover, diploid hepatocytes induced by carcinogens have been shown to be more responsive than polyploid hepatocytes to mitogenic stimuli by both EGF and insulin in vitro (35) . Therefore, the high susceptibility of a subpopulation of diploid hepatocytes to proliferation by EE treatment may account, at least in part, for a growth advantage of some of the DEN-induced diploid preneoplastic lesions during promotion by EE. This is in agreement with our previous studies (17) , in which we described that the promoting effects of EE only took place in a minority of the preneoplastic foci induced by DEN, thus resulting in an effective increase in the incidence of hepatic tumors by EE promotion.
In summary, the promoting ability of EE in hepatocarcinogenesis observed previously (17) seems to be related to its chronic effects on hepatocyte proliferation, the acute liver hyperplastic effects being unlikely to have a role. Moreover, a less differentiated or younger subpopulation of hepatocytes in the normal liver responded preferentially to the chronic activation of hepatocellular proliferation by EE: diploid hepatocytes found in periportal regions of the hepatic lobule. This may be a mechanism for the enhancement of the growth of certain diploid preneoplastic lesions during EE promotion.
